Back to search
FDAFDA · Food and drugs·Recall number D-0998-2017

Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed by OMP, Inc., Long Beach, CA Made in USA, NDC 62032-222-02

Published July 26, 2017 · Recall initiated: June 28, 2017

Summary

FDA records drug Class III recall D-0998-2017, published July 26, 2017 and initiated June 28, 2017. Recalling firm: Valeant Pharmaceuticals North America LLC; Status: Terminated; Reported quantity: 844 bottles; Lot: Lot #: 2578400, 0Exp 8/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Valeant Pharmaceuticals North America LLC
Distributor
U.S. Nationwide
Lot
Lot #: 2578400, 0Exp 8/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed by OMP, Inc., Long Beach, CA Made in USA, NDC 62032-222-02 recalled?

Yes. FDA published recall D-0998-2017 on July 26, 2017. Reported hazard: Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.

What should I do if I have this product?

Voluntary: Firm initiated · Letter